ADAC gets FDA nod for IMRT software

Nuclear medicine and radiation therapy firm ADAC Laboratories has received Food and Drug Administration 510(k) clearance for its P3IMRT intensity modulated radiation therapy (IMRT) inverse planning software. P3IMRT will be deployed with the Milpitas, CA-based firm’s Pinnacle3 radiation therapy planning product.

By AuntMinnie.com staff writers
February 12, 2001

Related Reading

Philips to re-enter nuclear medicine market with bid to buy ADAC, November 13, 2000

Copyright © 2001 AuntMinnie.com

Page 1 of 462
Next Page